[go: up one dir, main page]

GB201208536D0 - Dosing regimen - Google Patents

Dosing regimen

Info

Publication number
GB201208536D0
GB201208536D0 GBGB1208536.1A GB201208536A GB201208536D0 GB 201208536 D0 GB201208536 D0 GB 201208536D0 GB 201208536 A GB201208536 A GB 201208536A GB 201208536 D0 GB201208536 D0 GB 201208536D0
Authority
GB
United Kingdom
Prior art keywords
dosing regimen
regimen
dosing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1208536.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cyclacel Ltd
Original Assignee
Cyclacel Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cyclacel Ltd filed Critical Cyclacel Ltd
Priority to GBGB1208536.1A priority Critical patent/GB201208536D0/en
Publication of GB201208536D0 publication Critical patent/GB201208536D0/en
Priority to JP2015512121A priority patent/JP6286421B2/en
Priority to PCT/GB2013/051236 priority patent/WO2013171473A1/en
Priority to US14/401,357 priority patent/US9872874B2/en
Priority to EP13725424.9A priority patent/EP2874631A1/en
Ceased legal-status Critical Current

Links

GBGB1208536.1A 2012-05-15 2012-05-15 Dosing regimen Ceased GB201208536D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB1208536.1A GB201208536D0 (en) 2012-05-15 2012-05-15 Dosing regimen
JP2015512121A JP6286421B2 (en) 2012-05-15 2013-05-14 Administration regimen of sapacitabine and sericivrib
PCT/GB2013/051236 WO2013171473A1 (en) 2012-05-15 2013-05-14 Dosage regimen for sapacitabine and seliciclib
US14/401,357 US9872874B2 (en) 2012-05-15 2013-05-14 Dosage regimen for sapacitabine and seliciclib
EP13725424.9A EP2874631A1 (en) 2012-05-15 2013-05-14 Dosage regimen for sapacitabine and seliciclib

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1208536.1A GB201208536D0 (en) 2012-05-15 2012-05-15 Dosing regimen

Publications (1)

Publication Number Publication Date
GB201208536D0 true GB201208536D0 (en) 2012-06-27

Family

ID=46458868

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1208536.1A Ceased GB201208536D0 (en) 2012-05-15 2012-05-15 Dosing regimen

Country Status (1)

Country Link
GB (1) GB201208536D0 (en)

Similar Documents

Publication Publication Date Title
IL254716B (en) Zinc-lysine complex
PT3329965T (en) Dosing regimen of anti-alpha4beta7-antibodies
AP00462S1 (en) Container
GB201221389D0 (en) Metered pourer
IL237373B (en) Dosing regimen of sedative
ZA201406533B (en) Package
ZA201404702B (en) Packaging
EP2908103A4 (en) Flowmeter
PL2854737T3 (en) Packaging
PL2830964T3 (en) Packaging
PL2909091T3 (en) Improved packaging
GB2501959B (en) Shelf-ready packaging
AU347047S (en) Packaging
EP2832655A4 (en) Slide package
GB201304962D0 (en) Packaging
ZA201503058B (en) Packaging
PL2841885T3 (en) Dosing device
EP2939667A4 (en) Packaging
GB2508624B (en) Package
GB2501894B (en) Cycle
GB201220789D0 (en) Packaging
GB201208536D0 (en) Dosing regimen
GB201304599D0 (en) Dosing regimen
GB201205538D0 (en) Two part container
GB201214005D0 (en) Packaging one

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)